An overview of key policies and additional details on overall feasibility by election outcome have been summarized in these supplemental materials.
From the senior members of the U.S. L.E.K. Consulting Healthcare Services team:
Wiley Bell, Managing Director
Max Cambras, Managing Director
Kevin Grabenstatter, Managing Director
Jonathan Kfoury, Managing Director
Rosie Jiang, Global Healthcare Specialist
Max Reik, Senior Associate Consultant
Sam Rude, Senior Associate Consultant
Please reach out to us if you would like to continue the discussion.
L.E.K. Consulting’s Inaugural Clinical and eClinical Pharma Services Survey
Life Sciences & Pharma
Viral-Based Gene Therapy: Key Challenges and Bioprocessing Innovations